Planned phase I first-in-human trial of long-acting letrozole ISM.
Phase of Trial: Phase I
Latest Information Update: 30 Jul 2015
Price : $35 *
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- 30 Jul 2015 According to Rovi media release, this trial is expected to start by first half of 2016.
- 01 Aug 2013 Initiation of this trial is expected in the first half of 2015, according to a Rovi media release.
- 01 Aug 2013 New trial record